Publications
-
García-Albéniz X; Alonso, V; Escudero, P; Méndez M; Gallego, J; Rodríguez JR; Salud, A; Fernández-Plana J; Manzano, H; Zanui, M; Falc?, E; Feliu, J; Gil, M; Fernández-Martos C; Bohn, U; Alonso, C; Calderero, V; Rojo, F; Cuatrecasas, M; Maurel, J
Prospective Biomarker Study in Advanced RAS Wild-Type Colorectal Cancer: POSIBA Trial (GEMCAD 10-02)
Oncologist 24 1115-1122. .
-
Fernandez-Martos, C; Pericay, C; Losa, F; Garcia-Carbonero, R; Layos, L; Rodriguez-Salas, N; Martin-Richard, M; Alonso-Orduna, V; Vera, R; Gallego, J; Capdevila, J; Salud, A; Nogue, M; Maurel, J; Guash, I; Montagut, C; Lopez, C; Macias, I; Jain, RK; Garcia-Albeniz, X
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma The GEMCAD 1402 Randomized Clinical Trial
JAMA Oncology 5 1566-1573. .
-
Porcel, JM; Esquerda, A; Bielsa, S; Novell, A; Sorolla, MA; Gatius, S; Zamora, C; Vidal, S; Salud, A
Epithelial cell adhesion molecule (EpCAM) from pleural fluid cell lysates is a highly accurate diagnostic biomarker of adenocarcinomatous effusions
RESPIROLOGY 24 799-804. .
-
Carrato, A; Benavides, M; Massuti, B; Ferreiro-Monteagudo, R; García Alfonso P; Falco, E; Reboredo, M; Cano, T; Gallego, J; Vieitez, JM; Layos, L; Salud, A; Polo, E; Dotor, E; Duran-Ogalla, G; Rodriguez-Garrote, M; Calvo, A; Grande, E; Aranda, E
First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Bmc Cancer 19 533-533. .
-
Rivera, F; Romero, C; Jimenez-Fonseca, P; Izquierdo-Manuel, M; Salud, A; Martinez, E; Jorge, M; Arrazubi, V; Mendez, JC; Garcia-Alfonso, P; Reboredo, M; Barriuso, J; Muñoz-Unceta N; Jimeno, R; Lopez, C
Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial
CANCER CHEMOTHERAPY AND PHARMACOLOGY 83 1175-1181. .
-
Santos C; Azuara D; Viéitez JM; Páez D; Falcó E; Élez E; López-López C; Valladares M; Robles-Díaz L; García-Alfonso P; Bugés C; Durán G; Salud A; Navarro V; Capellá G; Salazar R; Aranda E
Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial
ANNALS OF ONCOLOGY 30 796-803. .
-
MORALES MURILLO, SERAFIN; GASOL CUDOS, ARIADNA; VELASCO SANCHEZ, ANA; MARTINEZ ORTIN, DAVID; SALLA FORTUNY, JOEL; TEJERO NARBONA, RUBEN; SERRATE LOPEZ, ANNA ALBA; VILARDELL VILLELLAS, FELIPE; SALUD SALVIA, ANTONIA
Clinical and Biological Factors Associated with ISH Amplification in HER2 2+ by IHC in Breast Cancer Patients
Biomedical Journal of Scientific & Technical Research -. .
-
Diaz-Serrano, A; Angulo, B; Dominguez, C; Pazo-Cid, R; Salud, A; Jimenez-Fonseca, P; Leon, A; Galan, MC; Alsina, M; Rivera, F; Plaza, JC; Paz-Ares, L; Lopez-Rios, F; Gomez-Martin, C
Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab
Oncologist 23 1092-1102. .
-
Alonso, V; Escudero, P; Fernandez-Martos, C; Salud, A; Mendez, M; Gallego, J; Rodriguez, JR; Martin-Richard, M; Fernandez-Plana, J; Manzano, H; Mendez, JC; Zanui, M; Falco, E; Gil-Raga, M; Rojo, F; Cuatrecasas, M; Feliu, J; Garcia-Albeniz, X; Maurel, J
Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients
NEOPLASIA 20 678-686. .
-
Feliu, J; Salud, A; Losada, EP; Alonso, V; Cubillo, A; Soler, G
First-line treatment with panitumumab plus FOLFIRI in elderly patients with RAS/BRAF wild-type unresectable metastatic colorectal cancer and good performance status: OPALO trial.
Journal of Clinical Oncology 36 -. .
-
Codony-Servat, J; Cuatrecasas, M; Asensio, E; Montironi, C; Martinez-Cardus, A; Marin-Aguilera, M; Horndler, C; Martinez-Balibrea, E; Rubini, M; Jares, P; Reig, O; Victoria, I; Gaba, L; Martin-Richard, M; Alonso, V; Escudero, P; Fernandez-Martos, C; Feliu, J; Mendez, JC; Mendez, M; Gallego, J; Salud, A; Rojo, F; Castells, A; Prat, A; Rosell, R; Garcia-Albeniz, X; Camps, J; Maurel, J
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer
BRITISH JOURNAL OF CANCER 117 1777-1786. .
-
Porcel, JM; Sole, C; Salud, A; Bielsa, S
Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion
Lung 195 775-779. .
Projects
- Decodificación de la metástasis del cáncer colorrectal desentrañando el señalosoma de PLA2G12A
- Ajuts per a la contractació de personal investigador novell (FI)
- Predicción de micrometástasis en pacientes con cáncer de colon localizado de alto riesgo
- Dimerizaciones de HER2 como elemento de decición en la terapia dirigida anti-HER2 frente al cáncer de mama
- UTILITAT PRONOSTICA DELS PERFILS D'EXPRESSIO PROTEICA EN PACIENTS AMB TUMOR RESIDUAL VIABLE (>1.0 CM) DESPRES DE LA QUIMIOTERAPIA NEOADJUVANT EN CANCER DE MAMA
- Cáncer de mama: utilidad pronóstica de los Perfiles de Expresión Proteica en pacientes con tumor residual viable (>1.0 cm) tras quimioterapia neoadyuvante
